UK markets close in 6 hours 19 minutes

NovaBay Pharmaceuticals, Inc. (NBY)

NYSE American - NYSE American Delayed price. Currency in USD
Add to watchlist
0.1410+0.0092 (+6.98%)
At close: 04:00PM EDT
0.1440 +0.00 (+2.13%)
Pre-market: 05:11AM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Cash flows from operating activities
Net income
-2,560
-9,640
-10,608
-5,824
-11,039
-
Depreciation & amortisation
447
203
483
119
51
-
Stock-based compensation
591
291
220
1,153
701
-
Change in working capital
-846
750
533
-38
210
-
Accounts receivable
-276
1,214
-305
452
-317
-
Inventory
-730
560
-217
-243
-116
-
Accounts payable
-776
-1,158
667
-163
321
-
Other working capital
-9,883
-4,150
-6,766
-9,244
-4,747
-
Other non-cash items
-
1,982
1,361
-
89
688
Net cash provided by operating activities
-9,763
-4,131
-6,654
-9,192
-4,721
-
Cash flows from investing activities
Investments in property, plant and equipment
-120
-19
-112
-52
-26
-
Acquisitions, net
-
-
0
-11,993
0
0
Net cash used for investing activities
-12,113
-19
-112
-12,045
-26
-
Cash flows from financing activities
Debt repayment
-105
-1,474
-105
0
-2,563
-
Common stock issued
-218
-
0
1,776
5,220
6,698
Other financing activities
-202
-181
-
-
-
-202
Net cash used provided by (used for) financing activities
16,393
1,910
4,633
16,789
9,762
-
Net change in cash
-5,483
-2,240
-2,133
-4,448
5,015
-
Cash at beginning of period
9,503
5,846
7,979
12,427
7,412
-
Cash at end of period
4,020
3,606
5,846
7,979
12,427
-
Free cash flow
Operating cash flow
-9,763
-4,131
-6,654
-9,192
-4,721
-
Capital expenditure
-120
-19
-112
-52
-26
-
Free cash flow
-9,883
-4,150
-6,766
-9,244
-4,747
-